The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology.
EUFEMED has been recognized as a stakeholder by EMA and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
EUFEMED is a not for profit association established under the Belgian law.
In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other societies and additional countries are invited to become members.
EUFEMED represents national and European federations, organisations or associations active in early clinical medicines development.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a “voice” in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Upcoming meetings & events
Invited speaker presentations Our invited speakers were an integral part of the EUFEMED conference and we are delighted to be able to share their presentations with you. Please click on… Read More
EUFEMED will be hosting it’s next meeting in Lyon, France on 15-18 May 2019. The venue will be the Centre de Congrès de Lyon. More news coming soon.
EUFEMED will be hosting a meeting in the Czech Republic in April – May 2021. The city will be Prague, but the final dates and venue are still to be… Read More
Get in touch
If you are interested in working together, send us an inquiry and we will get back to you as soon as we can!Contact us